These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21482446

  • 1. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling.
    Al-Najjar BO, Wahab HA, Tengku Muhammad TS, Shu-Chien AC, Ahmad Noruddin NA, Taha MO.
    Eur J Med Chem; 2011 Jun; 46(6):2513-29. PubMed ID: 21482446
    [Abstract] [Full Text] [Related]

  • 2. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.
    Al-Sha'er MA, Taha MO.
    J Chem Inf Model; 2010 Sep 27; 50(9):1706-23. PubMed ID: 20831219
    [Abstract] [Full Text] [Related]

  • 3. Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads.
    Shahin R, Taha MO.
    Bioorg Med Chem; 2012 Jan 01; 20(1):377-400. PubMed ID: 22112539
    [Abstract] [Full Text] [Related]

  • 4. Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors.
    Suaifan GA, Shehadehh M, Al-Ijel H, Taha MO.
    J Mol Graph Model; 2012 Jul 01; 37():1-26. PubMed ID: 22609742
    [Abstract] [Full Text] [Related]

  • 5. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
    Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S.
    J Med Chem; 2008 Oct 23; 51(20):6478-94. PubMed ID: 18808096
    [Abstract] [Full Text] [Related]

  • 6. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G.
    J Mol Graph Model; 2010 Jan 23; 28(5):383-400. PubMed ID: 19850503
    [Abstract] [Full Text] [Related]

  • 7. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH, Taha MO.
    J Mol Graph Model; 2011 Apr 23; 29(6):843-64. PubMed ID: 21376648
    [Abstract] [Full Text] [Related]

  • 8. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM, Taha MO.
    J Chem Inf Model; 2009 Apr 23; 49(4):978-96. PubMed ID: 19341295
    [Abstract] [Full Text] [Related]

  • 9. Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors.
    Al-Sha'er MA, VanPatten S, Al-Abed Y, Taha MO.
    J Mol Graph Model; 2013 May 23; 42():104-14. PubMed ID: 23603608
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
    Taha MO, Al-Sha'er MA, Khanfar MA, Al-Nadaf AH.
    Eur J Med Chem; 2014 Sep 12; 84():454-65. PubMed ID: 25050878
    [Abstract] [Full Text] [Related]

  • 14. Discovery of new β-D-galactosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening.
    Abdula AM, Khalaf RA, Mubarak MS, Taha MO.
    J Comput Chem; 2011 Feb 12; 32(3):463-82. PubMed ID: 20730780
    [Abstract] [Full Text] [Related]

  • 15. Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors.
    Khanfar MA, Taha MO.
    J Chem Inf Model; 2013 Oct 28; 53(10):2587-612. PubMed ID: 24050502
    [Abstract] [Full Text] [Related]

  • 16. Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.
    Shahin R, Alqtaishat S, Taha MO.
    J Comput Aided Mol Des; 2012 Feb 28; 26(2):249-66. PubMed ID: 22167443
    [Abstract] [Full Text] [Related]

  • 17. Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors.
    Abuhamdah S, Habash M, Taha MO.
    J Comput Aided Mol Des; 2013 Dec 28; 27(12):1075-92. PubMed ID: 24338032
    [Abstract] [Full Text] [Related]

  • 18. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM, Mohammad MK, Taha MO.
    ChemMedChem; 2008 Nov 28; 3(11):1763-79. PubMed ID: 18989859
    [Abstract] [Full Text] [Related]

  • 19. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N.
    J Mol Graph Model; 2007 Mar 28; 25(6):870-84. PubMed ID: 17035054
    [Abstract] [Full Text] [Related]

  • 20. Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
    Tayyem RF, Zalloum HM, Elmaghrabi MR, Yousef AM, Mubarak MS.
    Eur J Med Chem; 2012 Oct 28; 56():70-95. PubMed ID: 22960695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.